Clin2
NCT04167332Possibly a fitNot yet recruiting

Sample collection study for certain bladder cancer types

Bladder Cancer

Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study collects your medical information and tissue/biologic samples before bladder surgery. The goal is to better study specific types of bladder cancer, which may help future diagnosis and treatment decisions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
630 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have symptoms and/or scans that strongly suggest bladder cancer.
  • Your planned surgery includes taking part in sample and data collection before the operation.
  • Your bladder cancer pathology diagnosis must be transitional cell carcinoma (TCC), including its variants.
  • Your cancer must be non–muscle-invasive, such as CIS, Ta (stays in the bladder lining), or T1 (into the tissue under the lining).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04235764Recruiting
Testing a new bladder-tumor surgery tool for removed tissue

This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.

Bethesda, Maryland
NCT00026884Recruiting
Blood and tissue sample collection for cancer research

This study collects blood and tissue samples from people with cancer or suspected cancer, or from their blood relatives. Researchers use these samples to better understand cancer and develop new treatments.

Bethesda, Maryland
NCT07581496Recruiting
Blood test to detect bladder cancer DNA after surgery

This study examines whether a simple blood test can detect cancer DNA (circulating tumor DNA, or ctDNA) in patients with a specific type of bladder cancer. Detecting this DNA in blood may help doctors predict how the cancer will behave and guide future treatment decisions.

Basel
NCT03413982Recruiting
Bladder cancer blood and tissue study for new tests and treatments

This study collects samples from people who may have bladder cancer or already have a bladder cancer diagnosis. Those samples will help researchers develop better biomarkers (lab tests) and new therapies in the future.

Kansas City, Kansas
NCT04970472Recruiting
Urothelial bladder cancer sample collection for adults

This trial collects clinical samples from adults who have suspected or confirmed urothelial (bladder/urinary tract lining) cancer. It helps researchers study the disease and may support future improvements in diagnosis or treatment.

Toulouse
NCT02379429Recruiting
Collecting bladder/urothelial cancer tissue for future research

This study looks at urothelial cancer (often bladder cancer) samples taken during diagnosis or standard treatment. It may help researchers better understand the disease by using tissue that doctors already need to collect for care.

Bethesda, Maryland

Hear when a new Bladder Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.